• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

6.020 +0.140 (+2.38%)
Streaming Delayed Price Updated: 1:51 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 317,162
Open 5.820
Bid (Size) 6.010 (6)
Ask (Size) 6.030 (3)
Prev. Close 5.880
Today's Range 5.820 - 6.215
52wk Range 1.380 - 7.340
Shares Outstanding 348,875,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025
July 25, 2025
From Agenus Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
July 07, 2025
 
Via Benzinga

Performance

YTD
+94.8%
+94.8%
1 Month
+31.7%
+31.7%
3 Month
+97.4%
+97.4%
6 Month
+69.1%
+69.1%
1 Year
-7.2%
-7.2%

More News

Read More
Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3
July 07, 2025
From Agenus Inc.
Via Business Wire
Earnings Scheduled For May 12, 2025
May 12, 2025
Via Benzinga
Agenus's Earnings: A Preview
May 09, 2025
Via Benzinga
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
June 17, 2025
From Agenus Inc.
Via Business Wire
Agenus Announces Virtual Annual Shareholders Meeting
June 10, 2025
From Agenus Inc.
Via Business Wire
Analyst Upgrades Agenus As Zydus Deal Alleviates Cash Overhang
June 04, 2025
Via Benzinga
Agenus Stock Is Trading Higher Tuesday: What's Going On?
June 03, 2025
Via Benzinga
Tuesday's pre-market session: top gainers and losers
June 03, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 03, 2025
Via Benzinga
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US
June 03, 2025
From Agenus Inc.
Via Business Wire
Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
June 03, 2025
Via Benzinga
Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer
May 30, 2025
From Agenus Inc.
Via Business Wire
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
May 15, 2025
From Agenus Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
May 12, 2025
Via Benzinga
Agenus Reports Q1 2025 Financial Results and Key Business Updates
May 12, 2025
From Agenus Inc.
Via Business Wire
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
May 12, 2025
From Agenus Inc.
Via Business Wire
Agenus to Provide Corporate Update and First Quarter 2025 Financial Report
April 29, 2025
From Agenus Inc.
Via Business Wire
Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
April 28, 2025
From Agenus Inc.
Via Business Wire
Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
April 25, 2025
From Agenus Inc.
Via Business Wire
Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025
April 23, 2025
From Agenus Inc.
Via Business Wire
Here are the top movers in Tuesday's session.
April 22, 2025
Via Chartmill
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
March 25, 2025
From Agenus Inc.
Via Business Wire
Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
March 19, 2025
From Agenus Inc.
Via Business Wire

Frequently Asked Questions

Is Agenus Inc. - Common Stock publicly traded?
Yes, Agenus Inc. - Common Stock is publicly traded.
What exchange does Agenus Inc. - Common Stock trade on?
Agenus Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agenus Inc. - Common Stock?
The ticker symbol for Agenus Inc. - Common Stock is AGEN on the Nasdaq Stock Market
What is the current price of Agenus Inc. - Common Stock?
The current price of Agenus Inc. - Common Stock is 6.020
When was Agenus Inc. - Common Stock last traded?
The last trade of Agenus Inc. - Common Stock was at 07/30/25 01:51 PM ET
What is the market capitalization of Agenus Inc. - Common Stock?
The market capitalization of Agenus Inc. - Common Stock is 2.10B
How many shares of Agenus Inc. - Common Stock are outstanding?
Agenus Inc. - Common Stock has 2B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap